SI
SI
discoversearch

Biotech / Medical
ProMetic Life Sciences
An SI Board Since April 2016
Posts SubjectMarks Bans Symbol
167 10 0 PLI
Emcee:  axial Type:  Moderated
PROMETIC LIFE SCIENCES — prometic.com

ProMetic is a biopharmaceutical corporation with globally recognized expertise in bioseparation and uses its own affinity technology for the development of best in class plasma-derived therapeutics. ProMetic is also active in developing its own novel small molecule therapeutics products. Headquartered in Laval, Canada, ProMetic has a global presence through its various sites in the UK and USA, providing both manufacturing and R&D capability. These strategic locations facilitate ProMetic’s growth globally and supports all business activity in American, European and Asian markets. ProMetic is publicly traded on TSX (Symbol: PLI) and OTCQX (Symbol: PFSCF).

ProMetic has developed core competencies in strategic fields, including:
  • Purification of biologics
  • Drug development
  • Proteomics
  • Elimination of pathogens
LINK: Prometic press releases

The business is now focused on developing its range of therapeutics from both its plasma-derived and small-molecule platform.
______________________________________________________________________________________


WELCOME! —This is a moderated board. No spam, ad hominem attacks or flaming. One warning.
______________________________________________________________________________________
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
167New Prometic videos — [1] Virtual Tour of Prometic Life Science's Manufactaxial-January 4
166Not bad ... [graphic] Jimaxial1January 4
165A cheer for the prosperous New Year!Leo Fisher-12/25/2017
164Thanks Jim. Merry Christmas to you, too! And may we all have a Happy, Healthy, Cush-12/25/2017
163Cush, to you and our other readers: be well in 2018. Merry Christmas! Jaxial-12/25/2017
162Followup — No content changed. Edited for clarity. A few questions on latest PRaxial112/20/2017
161Yes, I agree Jim. The next six months are going to be very interesting. HaveCush-12/19/2017
160Hi Cush — Sometime soon, we should discuss off-label uses for PBI-4050 and Ryplaaxial112/19/2017
159PROMETIC’S PLASMINOGEN (RYPLAZIM™) GRANTED ORPHAN DRUG DESIGNATION FOR THE TREATCush112/18/2017
158PROMETIC’S PBI-4050 RECEIVES PROMISING INNOVATIVE MEDICINE (PIM) DESIGNATION FRaxial-12/11/2017
157PIVOTAL DATA FOR PROMETIC’S INTRAVENOUS PLASMINOGEN REPLACEMENT THERAPY TO BE PRaxial-12/6/2017
156BNN videos, recent — What's next for Prometic Life Sciences ProMetic Lifaxial-12/5/2017
155Thanks, Leo — "Dilutions do hurt a bit". Agreed. As many have noted,axial-12/3/2017
154Jim, Thanks for the continuous updates! Still holding strong. Dilutions do hurtLeo Fisher-12/3/2017
153PROMETIC ANNOUNCES THE CLOSING OF ITS USD $80 MILLION (CAD $100 MILLION) LINE Oaxial-12/1/2017
152PROMETIC REPORTS POSITIVE INTERIM CLINICAL DATA FROM ONGOING INTRAVENOUS IMMUNOaxial-12/1/2017
15130 Nov 2017: Recent analyst reports — http://docdro.id/n1DzGTN Hat tip: saxial-11/30/2017
150New findings from late-stage clinical trial evaluating IVIG in patients sufferinstocker22-11/23/2017
149PROMETIC REPORTS POSITIVE INTERIM CLINICAL DATA FROM ONGOING INTRAVENOUS IMMUaxial-11/22/2017
148'RDR:How is Ryplazim administered? Laurin: It is an infusion that initiallyaxial-11/17/2017
147CORPORATE PRESENTATION TO ACCOMPANY Q3/17 WEBCAST — prometic.com Jimaxial-11/15/2017
146TRANSCRIPT — PROMETIC WEBCAST Q3 2017 stockhouse.com Jimaxial-11/15/2017
145RBC report — Q3 2017 docdro.id [graphic] Jimaxial-11/15/2017
144PROMETIC REPORTS 2017 THIRD QUARTER HIGHLIGHTS AND FINANCIAL RESULTS US $80 milaxial111/13/2017
143Plasminogen Deficiency Awareness Week videos. youtube.com I hope that link Cush111/10/2017
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
Copyright © 1995-2018 Knight Sac Media. All rights reserved.Stock quotes are delayed at least 15 minutes - See Terms of Use.